Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-150-0 | CAS number: 63449-39-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Absorption of LCCPs via the oral and inhalation routes are predicted to be about 50 per cent of the administered dose. Absorption via the dermal route is predicted to be much lower (about 1 per cent of administered dose).
Key value for chemical safety assessment
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 1
- Absorption rate - inhalation (%):
- 50
Additional information
Basic Toxicokinetics
Limited toxicokinetic information is available for the LCCP products. The information available for LCCPs, as well as information available for intermediate length chlorinated paraffins (MCCP), have been reviewed by authorities (IPCS EHC 181, 1996; UK Environment Agency, 2009; OECD SIDS Dossier, 2009). These reviews predicted that absorption of LCCPs via the oral and inhalation routes will be significant (about 50 per cent of the administered dose).Absorption via the dermal route is predicted to be lower (about 1 per cent ofadministered dose). Absorption decreases with increasing carbon chain lengthand degree of chlorination.
Toxicokinetic information is available for a liquid grade C22–26, 43% chlorination LCCP product anda solid grade C22–26, 70% chlorination LCCP product. In conjunction with a standard 13-week repeated dose toxicity study, 18 rats of eachgender received a single dose of a radiolabelled C22–26, 43% chlorinated LCCP by theoral (gavage) route at 100 or 3,750 mg/kg (IRDC, 1984b). The animals were dosedeither after having received the respective dose level of unlabelled LCCP daily for 13weeks or having previously not been exposed to LCCP. Radioactivity in faeces andurine was monitored during the first seven days after radiolabelled LCCP dosing. Threeanimals per gender per group were killed at 0.5, 1, 2, 7, 28 and 90 days for collection oftissue and/or blood samples for radioactivity measurement.It was found that between 82 and 95 per cent of the administered radioactivity wasrecovered in the faeces during the seven-day collection period, most of which wasrecovered during the first two days. Between 0.1 and 0.8 per cent of the radiolabel wasexcreted in the urine. Blood concentrations of radioactivity in animals from the two dosegroups were very similar. Also, the inter-group differences in the concentration ofradioactivity for any given tissue were much less than the differences between theadministered dose. Tissue radioactivity levels were initially greatest in the liver but by90 days a redistribution to adipose tissue had occurred. This study suggests thatabsorption of the LCCP product may be saturable, but the extent of systemicabsorption and systemic elimination of LCCP could not be determined from this study.
Toxicokinetics of a C22–26, 70% chlorination product were investigated in a study ofidentical design (IRDC, 1984a). It was found that between 61 per cent and 88 per centof the administered radioactivity was recovered in the faeces during the seven-daycollection period. Only a very small proportion of the radioactivity (<0.1–1 per cent) wasexcreted in the urine. The highest levels of radioactivity were found in the liver, gonadsand adipose tissue seven days after dosing, with lower levels being found in the brain,kidney, blood and heart. As was the case with the C22–26, 43% chlorination LCCP study,the extent of systemic absorption and systemic elimination could not be determined.
A 14C-labelled chlorinated paraffin, C18; 50-53% Cl (CP-LH), was administered by gavage as a single dose of 500 mg/kg to three female Sprague-Dawley rats (Yang et al., 1987). After 24 h, 1% of the radioactive dose was recovered in the urine, 1.5% in the expired air and 22% in the faeces. After 96 h, 1.9% of the radioactive dose was recovered in the urine, 3.3% in the expired air, 5% in body tissue and 76% in the faeces.
Dermal Absorption
Chlorinated paraffins are slowly absorbed by the dermal route in Sprague-Dawley rats (Yang et al., 1987). Two 14C-labelled chlorinated paraffins, C18;50-53% Cl (CP-LH) and C28;47% Cl (CP-LL), were applied to rat skin (5-7 animals of each sex) at a concentration of 66 mg/cm2, approximately equivalent to 2000 mg/kg body weight. Only 0.7% (males) and 0.6% (females) of the C18 dose was absorbed after 96 h. Only 0.02% of the C28 dose was absorbed in males whereas in females the level was not detectable. This indicates that increasing chain length leads to decreased permeability. Of the absorbed C18 dose, 40% was exhaled as 14C-labelled CO2, and 20% was excreted in urine and 20% in faeces.
Theseresultsindicatethatratskinactsasaneffective barrier to chlorinatedparaffinscontainingeighteenormorecarbonsandmorethan40%chlorinebyweight.ThedermalabsorptionoftheCl8chlorinatedparaffinwasestimatedtobenearly100timeslessthantheoralabsorption.
Basedoncurrenttoxicityresultsfromrodentexperimentsandthesepresentfindings,chlorinatedparaffinsofthetypetestedwouldbeexpectedtohavelittleornoeffectinanimalsasa resultofdermalexposure.Ina review of limited comparativein vivodatafrom man and rat,(Wester andMaibach(1983)notedthatpercutaneousabsorptionisgenerallygreaterintherat.Thus,itis reasonabletosuggestthatchlorinatedparaffinsareunlikelytobesystemicallytoxictohumansbyskincontactunder normalconditions ofproductionand use.
References
International Programme on Chemical Safety Environmental Health Criteria #181, Chlorinated Paraffins, 1996.
UK Environment Agency (EA, of England and Wales) (2009). Environmental Risk Evaluation Report: Long-Chain Chlorinated Paraffins. January 2009.
OECD SIDS Assessment Report,Long Chain Chlorinated Paraffins (LCCPs).October, 2009
WESTER,R.C.andMAIBACH, H.J.(1983).Invivopercutaneous absorption. In:Dermatotoxicology(F.N. Marzulliand H.I.Maibach,eds.),pp. 131-146.Hemisphere,NewYork.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)